Singapore, Sept. 3 -- Neurophet, a South Korea-based artificial intelligence (AI) solution startup for brain disorders diagnosis and treatment has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (InRAD) to accelerate global standardisation of Alzheimer's and dementia-related data.

Through this agreement,Neurophet and InRAD aim to strengthen their collaboration to help establish globally harmonized standards for Alzheimer's disease and other dementias real-world data. The partnership also seeks to enable the seamless integration of AI-based neuroimaging technologies into the broader real-world data landscape, removing one of the key practical barriers to evi...